Top news of the week: 08.06.2022.
Upstream Bio Dives into Severe Asthma Space with $200M in Series A Financing
Upstream Bio is focusing its efforts on an experimental treatment for severe asthma licensed from Astellas Pharma.
Small Study of GSK Rectal Cancer Drug Yields "Unheard of" Results
In a small study of 14 rectal cancer patients, researchers at Memorial Sloan Kettering Cancer Center published results where 100% of the 12 patients who completed treatment went into ...
Novartis Latest Target in Cyberattack Extortion Plot
Novartis has fallen victim to a cyberattack. The Swiss pharma giant’s data was hijacked by a well-known online extortion ring dubbed Industrial Spy.
Investors Become Goldilocks in a Bear Market I AM BIO
Show I AM BIO, Ep Investors Become Goldilocks in a Bear Market - May 31, 2022
Aslan, Yumanity, Editas, Janssen and More Team Up to Fight Disease
Aslan partners with Johns Hopkins and Duke, Editas joins forces with Immatics, Yumanity (soon to be Kineta, Inc.) teams with Janssen, Serotiny & Janssen Biotech and Ginkgo and Novo Nordisk.
Improving Protein Therapeutic Production is a Key Goal of Biopharma 4.0
In this GENcast, we chatted with two team members and picked their brains about some of the challenges currently facing manufacturers in this space. Listen in and hear what they have to say…
Biotech Networks US Western Region & Remote Career Fair June 21 2022
Save your spot to chat with Seattle, Washington life science company NanoString. Each chat lasts about 10 mins and you can join from your desktop or smartphone anytime during the event. ...